Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DWP05195 in Postherpetic Neuralgia
NCT01557010Phase 2Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Mar 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of DWP05195 in postherpetic neuralgia (PHN), sponsored by Daewoong Pharmaceutical. Started Mar 2012; status: completed.
02
Drugs
DWP05195
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT01557010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01557010.